COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV
Introduction: Variants of COVID-19 are responsible for 700 million infections and 7 million deaths worldwide. Vaccinations have high efficiency in preventing infection and secondary benefits of reducing COVID-19 hospital admissions, attenuating disease severity and duration of illness. Conflicting r...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/16/12/1805 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850238926569078784 |
|---|---|
| author | Keren Mahlab-Guri Irina Komarova Laliv Kadar Shay Nemet Ramon Cohen Sara Radian-Sade Achiel Tova Alex Guri Shira Rosenberg-Bezalel Daniel Elbirt |
| author_facet | Keren Mahlab-Guri Irina Komarova Laliv Kadar Shay Nemet Ramon Cohen Sara Radian-Sade Achiel Tova Alex Guri Shira Rosenberg-Bezalel Daniel Elbirt |
| author_sort | Keren Mahlab-Guri |
| collection | DOAJ |
| description | Introduction: Variants of COVID-19 are responsible for 700 million infections and 7 million deaths worldwide. Vaccinations have high efficiency in preventing infection and secondary benefits of reducing COVID-19 hospital admissions, attenuating disease severity and duration of illness. Conflicting reports were published regarding COVID-19 among PLWH. Objective: The aim of this study was to evaluate COVID-19 morbidity, hospitalization, and the magnitude of immunological response to sequential BNT 162b2 mRNA vaccines in PLWH regarding demographic and clinical factors. Results: Our retrospective study included 784 PLWH who had at least one anti- SARS-CoV-2 antibody test between March 2021 and October 2021. Half of our patients (392) had CD4 cell counts above 500 cells/µL, 40.2% (315) had 200 < CD4 < 500 cells/µL and only 9.8% (77) had CD4 < 200 cells/µL at their last laboratory workup. The mean age was 50.2 ± 12.2 years. About 90% of our patients were given at least two doses of the BNT 162b2 Pfizer vaccines; about 60% received three doses of the vaccine. About a quarter of our patients (27.6%) had COVID-19 infection. Only six patients required hospital admission. All six patients recovered from COVID-19 infection. Titers of COVID-19 antibodies were lower for patients with CD4 cell counts of less than 200 cells/µL in the first, second, and third serological tests with statistical significance. In a multinomial logistic regression, the influence of other factors such as age, sex, and previous COVID-19 infection on first COVID-19 antibody titers was not significant. Conclusions: PLWH are responsive to COVID-19 vaccines. As was expected, patients with higher CD4 cell counts had higher titers of COVID-19 antibodies and lower hospitalization rate. Age, sex, and previous COVID-19 infection did not significantly affect antibody titers according to our study. Larger prospective studies with control groups are needed to further characterize immunologic response to COVID-19 vaccination among PLWH. |
| format | Article |
| id | doaj-art-74f7ab49b4974b92aa1b625f01f868bf |
| institution | OA Journals |
| issn | 1999-4915 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Viruses |
| spelling | doaj-art-74f7ab49b4974b92aa1b625f01f868bf2025-08-20T02:01:19ZengMDPI AGViruses1999-49152024-11-011612180510.3390/v16121805COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIVKeren Mahlab-Guri0Irina Komarova1Laliv Kadar2Shay Nemet3Ramon Cohen4Sara Radian-Sade5Achiel Tova6Alex Guri7Shira Rosenberg-Bezalel8Daniel Elbirt9Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelAllergy, Clinical Immunology and AIDS Center, Kaplan Medical Center, Rehovot 7680400, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelAllergy, Clinical Immunology and AIDS Center, Kaplan Medical Center, Rehovot 7680400, IsraelAllergy, Clinical Immunology and AIDS Center, Kaplan Medical Center, Rehovot 7680400, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem 9112102, IsraelIntroduction: Variants of COVID-19 are responsible for 700 million infections and 7 million deaths worldwide. Vaccinations have high efficiency in preventing infection and secondary benefits of reducing COVID-19 hospital admissions, attenuating disease severity and duration of illness. Conflicting reports were published regarding COVID-19 among PLWH. Objective: The aim of this study was to evaluate COVID-19 morbidity, hospitalization, and the magnitude of immunological response to sequential BNT 162b2 mRNA vaccines in PLWH regarding demographic and clinical factors. Results: Our retrospective study included 784 PLWH who had at least one anti- SARS-CoV-2 antibody test between March 2021 and October 2021. Half of our patients (392) had CD4 cell counts above 500 cells/µL, 40.2% (315) had 200 < CD4 < 500 cells/µL and only 9.8% (77) had CD4 < 200 cells/µL at their last laboratory workup. The mean age was 50.2 ± 12.2 years. About 90% of our patients were given at least two doses of the BNT 162b2 Pfizer vaccines; about 60% received three doses of the vaccine. About a quarter of our patients (27.6%) had COVID-19 infection. Only six patients required hospital admission. All six patients recovered from COVID-19 infection. Titers of COVID-19 antibodies were lower for patients with CD4 cell counts of less than 200 cells/µL in the first, second, and third serological tests with statistical significance. In a multinomial logistic regression, the influence of other factors such as age, sex, and previous COVID-19 infection on first COVID-19 antibody titers was not significant. Conclusions: PLWH are responsive to COVID-19 vaccines. As was expected, patients with higher CD4 cell counts had higher titers of COVID-19 antibodies and lower hospitalization rate. Age, sex, and previous COVID-19 infection did not significantly affect antibody titers according to our study. Larger prospective studies with control groups are needed to further characterize immunologic response to COVID-19 vaccination among PLWH.https://www.mdpi.com/1999-4915/16/12/1805HIVAIDSCOVID-19COVID-19 mRNA vaccinevaccination response |
| spellingShingle | Keren Mahlab-Guri Irina Komarova Laliv Kadar Shay Nemet Ramon Cohen Sara Radian-Sade Achiel Tova Alex Guri Shira Rosenberg-Bezalel Daniel Elbirt COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV Viruses HIV AIDS COVID-19 COVID-19 mRNA vaccine vaccination response |
| title | COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV |
| title_full | COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV |
| title_fullStr | COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV |
| title_full_unstemmed | COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV |
| title_short | COVID-19 Vaccinations, Infections, and Outcomes Among 784 People Living with HIV |
| title_sort | covid 19 vaccinations infections and outcomes among 784 people living with hiv |
| topic | HIV AIDS COVID-19 COVID-19 mRNA vaccine vaccination response |
| url | https://www.mdpi.com/1999-4915/16/12/1805 |
| work_keys_str_mv | AT kerenmahlabguri covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT irinakomarova covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT lalivkadar covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT shaynemet covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT ramoncohen covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT sararadiansade covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT achieltova covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT alexguri covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT shirarosenbergbezalel covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv AT danielelbirt covid19vaccinationsinfectionsandoutcomesamong784peoplelivingwithhiv |